GRCL - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GRCL RYZB BRBS | Benzinga
NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Gracell Biotechnologies Inc. (NASDAQ:GRCL)'s sale to AstraZeneca. Under the terms of the proposed transaction, AstraZeneca will acquire Gracell for $2.00 per ordinary share in cash at closing (equivalent to $10.00 per ADS of Gracell), plus a non-tradable contingent value right of $0.30 per ordinary share in cash (equivalent to $1.50 per ADS of Gracell) payable upon ...